NDC 0065-0002

NEVANAC

Nepafenac

NEVANAC is a Ophthalmic Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Alcon Laboratories, Inc.. The primary component is Nepafenac.

Product ID0065-0002_01a34750-69f1-4871-b8cf-1f5bc1badfdf
NDC0065-0002
Product TypeHuman Prescription Drug
Proprietary NameNEVANAC
Generic NameNepafenac
Dosage FormSuspension/ Drops
Route of AdministrationOPHTHALMIC
Marketing Start Date2005-09-06
Marketing CategoryNDA / NDA
Application NumberNDA021862
Labeler NameAlcon Laboratories, Inc.
Substance NameNEPAFENAC
Active Ingredient Strength1 mg/mL
Pharm ClassesCyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0065-0002-03

3 mL in 1 BOTTLE, PLASTIC (0065-0002-03)
Marketing Start Date2005-09-06
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0065-0002-01 [00065000201]

NEVANAC SUSPENSION/ DROPS
Marketing CategoryNDA
Application NumberNDA021862
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2005-09-06
Marketing End Date2018-02-09

NDC 0065-0002-03 [00065000203]

NEVANAC SUSPENSION/ DROPS
Marketing CategoryNDA
Application NumberNDA021862
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2005-09-06

Drug Details

Active Ingredients

IngredientStrength
NEPAFENAC1 mg/mL

OpenFDA Data

SPL SET ID:3ad48650-75e3-4c74-9302-01b0088f164e
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 603978
  • 578044
  • PHarm Class EPC
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • NUI Code
  • N0000000160
  • N0000175722
  • N0000175721
  • Pharmacological Class

    • Cyclooxygenase Inhibitors [MoA]
    • Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
    • Nonsteroidal Anti-inflammatory Drug [EPC]

    NDC Crossover Matching brand name "NEVANAC" or generic name "Nepafenac"

    NDCBrand NameGeneric Name
    0065-0002NEVANACnepafenac
    0078-0778NEVANACnepafenac
    0065-1750ILEVROnepafenac
    0078-0743ILEVROnepafenac

    Trademark Results [NEVANAC]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    NEVANAC
    NEVANAC
    78361073 3149473 Live/Registered
    NOVARTIS AG
    2004-02-02

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.